Skip to main content Accessibility help
×
Home

Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists

  • Danyael Lutgens (a1) (a2), Martin Lepage (a3) (a2), Rahul Manchanda (a4) (a5) and Ashok Malla (a3) (a6)

Extract

A sample of 206 Canadian psychiatrists who routinely treat patients with psychotic disorders were randomly surveyed regarding their knowledge and practice in relation to persistent negative symptoms of schizophrenia. Large majorities reported observing a high prevalence of persistent negative symptoms that do not respond to available treatments (83%), have a profound impact on functional outcomes (96.5%) and contribute to family burden. Almost half the sample (43%) recognised the importance of formally assessing persistent symptoms and nearly a third (30%) indicated that this was a part of their usual practice. These survey results correspond with recent consensus and highlight the importance and challenge of treating persistent negative symptoms in schizophrenia.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.

References

Hide All
Andreasen, N. C. & Olsen, S. (1982) Negative v positive schizophrenia: definition and validation. Archives of General Psychiatry, 39, 789.
Barnes, T. R. & Paton, C. (2011) Do antidepressants improve negative symptoms in schizophrenia? BMJ, 342, d3371.
Bow-Thomas, C. C., Velligan, D. I., Miller, A. L., et al (1999) Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatry Research, 86, 131142.
Buchanan, R. W. (2007) Persistent negative symptoms in schizophrenia: an overview. Schizophrenia Bulletin, 33, 10131022.
Cassidy, C. M., Lepage, M., Harvey, P. O., et al (2012) Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls. Schizophrenia Research, 137, 3944.
Corcoran, C., Kimhy, D., Parrilla-Escobar, M., et al (2011) The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine, 41, 251261.
Foussias, G., Mann, S., Zakzanis, K., et al (2009) Motivational deficits as the central link to functioning in schizophrenia: a pilot study. Schizophrenia Research, 115, 333337.
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., et al (2006) The NIMH MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin, 32, 214219.
Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., et al (2004) The Schizophrenia Patient Outcomes Research Team (PORT). Schizophrenia Bulletin, 30, 193217.
Malla, A. K., Norman, R., Manchanda, R., et al (2002) One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophrenia Research, 54, 231.
Malla, A. K., Bodnar, M., Joober, R., et al (2011) Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophrenia Research, 125, 1320.
Milev, P., Ho, B. C., Arndt, S., et al (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry, 162, 495506.
Möller, H. J. (2003) Management of the negative symptoms of schizophrenia. CNS Drugs, 17, 793823.
Möller, H. J. (2007) Clinical evaluation of negative symptoms in schizophrenia. European Psychiatry, 22, 380386.
Perlick, D., Rosenheck, R., Kaczynski, R., et al (2006) Special section on CATIE baseline data: components and correlates of family burden in schizophrenia. Psychiatric Services, 57, 11171125.
Rector, N. A. & Beck, A. T. (2001) Cognitive behavioral therapy for schizophrenia: an empirical review. Journal of Nervous and Mental Disease, 189, 278287.
Wykes, T., Steel, C. & Everitt, B. (2008) Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34, 523537.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists

  • Danyael Lutgens (a1) (a2), Martin Lepage (a3) (a2), Rahul Manchanda (a4) (a5) and Ashok Malla (a3) (a6)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *